Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dynamic cardiomyoplasty: current status and future perspective]

R C Chiu1, Y Misawa, T Hasegawa

  • 1Division of Cardiovascular and Thoracic Surgery, McGill University, Canada.

Rinsho Kyobu Geka = Japanese Annals of Thoracic Surgery
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent insights into the role of host innate and acquired immunity responses.

Ernst Schering Research Foundation workshop·2005
Same author

[Spinal cord ischemia after surgery for arch and aortic valve replacement with elephant trunk for plural thoracic aneurysms].

Kyobu geka. The Japanese journal of thoracic surgery·2004
Same author

Multilevel cycle of anthropogenic copper.

Environmental science & technology·2004
Same author

Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats.

Clinical and experimental immunology·2003
Same author

New horizons in the treatment of irritable bowel syndrome.

Drugs of today (Barcelona, Spain : 1998)·2003
Same author

[Sinus of Valsalva dilatation after replacement of the ascending aorta and aortic valve].

Kyobu geka. The Japanese journal of thoracic surgery·2003
Same journal

[A case report of ruptured dissecting aneurysm with thrombosed false lumen].

Rinsho kyobu geka = Japanese annals of thoracic surgery·1994
Same journal

[Two cases of tuberculous constrictive pericarditis].

Rinsho kyobu geka = Japanese annals of thoracic surgery·1994
Same journal

[Pulmonary hamartoma: atypical cases and current concept of management].

Rinsho kyobu geka = Japanese annals of thoracic surgery·1994
Same journal

[Mitral valve surgery using combined superior-transseptal approach to the left atrium].

Rinsho kyobu geka = Japanese annals of thoracic surgery·1994
Same journal

[A case of left atrial free-floating ball thrombus].

Rinsho kyobu geka = Japanese annals of thoracic surgery·1994
Same journal

[Multi-organ ischemia due to traumatic lesion of the descending thoracic aorta--a case-report].

Rinsho kyobu geka = Japanese annals of thoracic surgery·1994
See all related articles

Dynamic cardiomyoplasty shows excellent hemodynamic effects for heart failure patients. This surgical approach may serve as a bridge to heart transplantation or an alternative treatment for advanced heart failure.

Area of Science:

  • Cardiovascular Surgery
  • Regenerative Medicine
  • Biomedical Engineering

Context:

  • Heart failure is a progressive condition with limited treatment options.
  • Dynamic cardiomyoplasty (DCM) is an emerging surgical technique for advanced heart failure.
  • Previous studies indicate potential benefits but require further validation.

Purpose:

  • To evaluate the safety and efficacy of dynamic cardiomyoplasty.
  • To assess the hemodynamic effects and underlying mechanisms of DCM.
  • To explore DCM's potential role in myocardial remodeling and as a bridge to transplantation.

Summary:

  • Phase I and II studies demonstrate the safety and positive hemodynamic outcomes of dynamic cardiomyoplasty.
  • The procedure involves wrapping a patient's own muscle around the heart to assist its function.

Related Experiment Videos

  • Postoperative muscle adaptation may reduce cardiac wall stress and improve systolic function, increasing cardiac output and ejection fraction.

    • Impact:

    • Dynamic cardiomyoplasty shows promise in improving cardiac function and potentially delaying heart remodeling in patients with advanced heart failure.
    • Successful Phase III trials could establish DCM as a viable surgical treatment or a bridge to heart transplantation.
    • This approach may offer a new therapeutic avenue for patients ineligible for or awaiting transplantation.